Harald Petry
Geen lopende functies
Loopbaan van Harald Petry
Eerdere bekende functies van Harald Petry
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
UNIQURE N.V. | Hoofd Techniek/Wetenschap/O&O | 09-01-2012 | 07-08-2017 |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Hoofd Techniek/Wetenschap/O&O | 23-06-2010 | 11-03-2013 |
Berlex Biosciences | Corporate Officer/Principal | - | - |
Jenapharm GmbH & Co. KG
Jenapharm GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Jenapharm GmbH & Co. KG manufactures and distributes pharmaceutical products. It offers cures for erectile dysfunction, testosterone deficit, and hyperactivity. It also provides contraceptives, menopause pills, and food supplements. The company was founded in 1950 and is headquartered in Jena, Germany. | Corporate Officer/Principal | - | - |
Opleiding van Harald Petry
University of Giessen | Doctorate Degree |
Statistieken
Internationaal
Duitsland | 3 |
Nederland | 3 |
Verenigde Staten | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
UNIQURE N.V. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Jenapharm GmbH & Co. KG
Jenapharm GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Jenapharm GmbH & Co. KG manufactures and distributes pharmaceutical products. It offers cures for erectile dysfunction, testosterone deficit, and hyperactivity. It also provides contraceptives, menopause pills, and food supplements. The company was founded in 1950 and is headquartered in Jena, Germany. | Health Technology |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
Berlex Biosciences |
- Beurs
- Insiders
- Harald Petry
- Ervaring